JP5845807B2 - 炭酸含有内用液 - Google Patents
炭酸含有内用液 Download PDFInfo
- Publication number
- JP5845807B2 JP5845807B2 JP2011236775A JP2011236775A JP5845807B2 JP 5845807 B2 JP5845807 B2 JP 5845807B2 JP 2011236775 A JP2011236775 A JP 2011236775A JP 2011236775 A JP2011236775 A JP 2011236775A JP 5845807 B2 JP5845807 B2 JP 5845807B2
- Authority
- JP
- Japan
- Prior art keywords
- liquid
- internal
- carbon dioxide
- internal use
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims description 38
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 50
- 239000001569 carbon dioxide Substances 0.000 claims description 23
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 18
- -1 fatty acid ester Chemical class 0.000 claims description 15
- 210000004185 liver Anatomy 0.000 claims description 13
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 10
- 235000008397 ginger Nutrition 0.000 claims description 10
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 9
- 239000010813 municipal solid waste Substances 0.000 claims description 9
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims description 9
- 241000234314 Zingiber Species 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 230000002440 hepatic effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 241000202807 Glycyrrhiza Species 0.000 description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940010454 licorice Drugs 0.000 description 5
- 238000004040 coloring Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940116257 pepper extract Drugs 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical class FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Description
従って、本発明の課題は、前記の生薬と二酸化炭素を含有し、外観が良好で服用感にも優れた内用液を提供することにある。
また、本発明は、(A)ショウキョウ、肝臓水解物、ゴミシ、シゴカ及びイカリソウから選ばれる1種又は2種以上、並びに(B)ポリオキシエチレンポリオキシプロピレングリコール及び/又はポリオキシエチレンソルビタン脂肪酸エステルを含有する内用液に、二酸化炭素を封入することを特徴とする炭酸含有内用液の泡状着色物の発生抑制方法を提供するものである。
ポリオキシエチレンポリオキシプロピレングリコールのポリオキシエチレン数は20〜200が好ましく、ポリオキシプロピレン数は20〜70が好ましい。ポリオキシエチレンソルビタン脂肪酸エステルとしては、ポリオキシエチレンソルビタンC8-22脂肪酸エステルが好ましく、ポリオキシエチレンソルビタンモノC8-22脂肪酸エステルがより好ましい。またポリオキシエチレンソルビタン脂肪酸エステルのポリオキシエチレン数は、10〜40が好ましく、10〜30がより好ましく、約20が特に好ましい。より具体例にはポリオキシエチレンソルビタンモノラウリン酸エステル、ポリオキシエチレンソルビタンモノステアリン酸エステル、ポリオシキエチレンソルビタントリステアリン酸エステル、ポリオキシエチレンソルビタンモノオレイン酸エステルが挙げられ、ポリオキシエチレンソルビタンモノオレイン酸エステルが特に好ましい。
これらの成分は、1種を用いてもよいし、2種を組み合わせて用いてもよい。
ショウキョウ流エキス5mL、ポリオキシエチレンポリオキシプロピレングリコール(プルロニックF68)0.5g、クエン酸7g、水酸化ナトリウム適量、果糖ブドウ糖液糖40g、香料適量を精製水1000mLに溶解し、これに二酸化炭素をガスボリュームが2.5となるように封入して内用液を得た。
実施例1と同様にして、表1〜表12の内用液を製造した。
(1)二酸化炭素封入時の泡状着色物の発生の有無
二酸化炭素封入時の着色物の発生の有無を以下の基準で評価した。着色物が発生した状態の写真を図1に、着色物の発生が抑制された状態の写真を図2に示す。
着色物の析出が認められる:△
着色物の析出がほとんどない:○
着色物の析出が全くない:◎
得られた内用液を5名のパネラーが服用し、その服用感を評価した。
やや服用しにくい:△
服用しやすい:○
非常に服用しやすい:◎
得られた内用液を60℃に3週間保存後、2ヶ月冷蔵保存し、外観を評価した。
外観の劣化を生じる :△
ほとんど外観の劣化を生じない:○
外観の劣化を生じない :◎
一方、成分(B)に代えて、種々の非イオン性界面活性剤、消泡剤や増粘剤を添加しても十分な効果は得られなかった。
Claims (4)
- (A)ショウキョウ、肝臓水解物、ゴミシ、シゴカ及びイカリソウから選ばれる1種又は2種以上、並びに(B)ポリオキシエチレンポリオキシプロピレングリコール及び/又はポリオキシエチレンソルビタン脂肪酸エステルを含有し、(C)二酸化炭素を封入してなる炭酸含有内用液。
- 成分(A)の含有量が、肝臓水解物を除く生薬の原生薬換算量及び/又は肝臓水解物の含有量の合計で0.01〜1.5w/v%である請求項1記載の炭酸含有内用液。
- 成分(B)の含有量が0.001〜1.0w/v%である請求項1又は2記載の炭酸含有内用液。
- (A)ショウキョウ、肝臓水解物、ゴミシ、シゴカ及びイカリソウから選ばれる1種又は2種以上、並びに(B)ポリオキシエチレンポリオキシプロピレングリコール及び/又はポリオキシエチレンソルビタン脂肪酸エステルを含有する内用液に、二酸化炭素を封入することを特徴とする炭酸含有内用液の泡状着色物の発生抑制方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011236775A JP5845807B2 (ja) | 2011-10-28 | 2011-10-28 | 炭酸含有内用液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011236775A JP5845807B2 (ja) | 2011-10-28 | 2011-10-28 | 炭酸含有内用液 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013095670A JP2013095670A (ja) | 2013-05-20 |
JP5845807B2 true JP5845807B2 (ja) | 2016-01-20 |
Family
ID=48617997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011236775A Active JP5845807B2 (ja) | 2011-10-28 | 2011-10-28 | 炭酸含有内用液 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5845807B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6804190B2 (ja) * | 2015-11-25 | 2020-12-23 | エスエス製薬株式会社 | 医薬組成物 |
JP7167480B2 (ja) * | 2017-10-20 | 2022-11-09 | 大正製薬株式会社 | 経口液体組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54126188A (en) * | 1978-03-20 | 1979-10-01 | Crown Cork Japan | Antiifoaming container for beverage containing carbon dioxide |
JPH0657117B2 (ja) * | 1987-04-17 | 1994-08-03 | 熊本県 | 澄明生姜液及び澄明生姜液を用いた新規な飲料及びそれらの製造方法 |
KR890001471A (ko) * | 1987-07-22 | 1989-03-27 | 김성배 | 탄산음료 원액 조성물 |
KR890011553A (ko) * | 1988-01-11 | 1989-08-21 | 김성배 | 새로운 탄산음료 |
JP3864431B2 (ja) * | 1995-06-12 | 2006-12-27 | ゼリア新薬工業株式会社 | カンゾウの抽出物を配合した安定な液剤 |
JP4403587B2 (ja) * | 1998-07-21 | 2010-01-27 | 大正製薬株式会社 | 低pHで安定な生薬エキス配合液剤 |
ATE493039T1 (de) * | 2006-11-29 | 2011-01-15 | Stephenson Group Ltd | Verbesserungen an oder in zusammenhang mit kohlensäurehaltigen getränken |
JP5665306B2 (ja) * | 2009-11-20 | 2015-02-04 | サントリー食品インターナショナル株式会社 | 高甘味度甘味料を含有する炭酸飲料 |
-
2011
- 2011-10-28 JP JP2011236775A patent/JP5845807B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013095670A (ja) | 2013-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10272091B2 (en) | Theacrine-based supplement and method of use thereof | |
KR100323271B1 (ko) | 경구용 조성물의 불쾌한 맛의 억제 방법 | |
JP2015212283A (ja) | 使い捨ての容器およびその用途 | |
CN110382007A (zh) | 具有恢复的环境效应的组合物的快速和受控递送 | |
MX2008013257A (es) | Composiciones y estuches utiles para el tratamiento de enfermedades respiratorias. | |
US6998112B2 (en) | Sleep inducing toothpaste made with natural herbs and a natural hormone | |
US8105637B2 (en) | Composition comprising nanoparticle Ginkgo biloba extract with the effect of brain function activation | |
JP2002363105A (ja) | 不快な味のマスキング方法及び内服用液剤 | |
JP5845807B2 (ja) | 炭酸含有内用液 | |
US10028967B2 (en) | Medicament | |
JP2003231647A (ja) | 内服液組成物 | |
JP5543656B1 (ja) | ウコン中の有用成分を含有する組成物 | |
JP2008094743A (ja) | 摂食・嚥下改善食品 | |
JP2004161679A (ja) | 内服用液剤 | |
JP5602696B2 (ja) | プロアントシアニジンによる性的機能及び性器血管系の改善 | |
JP2007246402A (ja) | 内服用液剤 | |
US11864570B2 (en) | Therapeutic composition including carbonated solution | |
JP5388759B2 (ja) | 自閉症の改善薬、治療茶 | |
ES2319049B1 (es) | Composicion que comprende hidrolizado de colageno y acido hialuronico para la mejora de dificultades funcionales consecutivas a alteraciones de los cartilagos articulares. | |
JP2891738B2 (ja) | アルコール吸収抑制剤 | |
JP5359527B2 (ja) | 飲料 | |
WO2019131654A1 (ja) | 外用製剤 | |
JP6350157B2 (ja) | 内用液剤 | |
JP2022037146A (ja) | 飴 | |
JP2015065953A (ja) | ウコン中の有用成分を含有する飲料の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140723 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150623 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151027 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151109 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5845807 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |